Cisco Systems, Inc. (NASDAQ:CSCO) Announces UK’s Largest Mobile Networker Will Use Their Small Cells

Cisco Systems, Inc. (NASDAQ:CSCO) announced that EE, the UK’s largest mobile network operator, will be using the company’s small cells. Cisco’s small cell solutions are and end-to-end product and are scalable so as to be conformed to small, medium or large enterprise buildings. This is to support Cisco’s quickly growing base of enterprise customers. The mobile enterprise industry is growing quickly and the amount of mobile data that will be needed to be transferred is growing even faster. Wi-Fi is becoming more and more common and expected by consumers. Businesses are realizing the value of offering free Wi-Fi access at their establishments and this is contributing greatly to the growth explosion.

Read what this analyst has to say about CSCO.

Innovative Design And Implementation

The system using a standalone access points along with a small cell solution to support modules that can be plugged in to existing Wi-Fi points. The installation is simple when compared to those of traditional in-building types. The cells coordinate automaticallyto provide complete coverage and minimize the need for complicated configurations and implementations. The approach is innovative and provides the strongest mobile services along with large coverage areas and seamless user experiences.

Mobile Growth

In a recently released Cisco publication on the industry, it forecast that mobile data traffic will grow by 10 times its current levels over the next five years. This creates an urgent need for mobile network solutions that are quickly implemented and do not have the complex configurations of other offerings. Most of that growth is attributed to indoor growth, which includes enterprise networks for buildings including educational and commercial uses. Cisco Systems, Inc. (NASDAQ:CSCO) has always been referred to as the company the Internet is built on and with the move to mobile technology it is attempting to retain that title.

Technicals

The stock is still trading at its all-time highs but it is also doing some nice early-stage base building. There is big support just below $28.50 and for now the stock is very healthy. Volume has been consistent and the issue continues to get solid attention.

About the Author

John is a special projects and general assignment reporter, noted for breaking several exclusive stories.

Leave A Response